Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444 · cited 1×
“It has been noticed that glucose fluctuations (glucose swing) during postprandial periods exhibit a more specific triggering effect on oxidative stress than chronic hyperglycaemia [9].”
BackgroundCoutinho, M., Gerstein, H. C., Wang, Y., & Yusuf, S. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.233 · Cited by 1,685 · cited 1×
“tion between fasting blood glucose (FBG) and cardiovascular events [6, 7].”
BackgroundMeta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus
Selvin, E., Marinopoulos, S., Berkenblit, G., Rami, T., Brancati, F. L., Powe, N. R., & Golden, S. H. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-6-200409210-00007 · Cited by 1,657 · cited 1×
“The major cause of the reduction in life expectancy in diabetic patients is associated with cardiovascular complications [ 1 , 2]. Quantitatively, subjects with diabetes have more than two-fold increased risk for cardiovascular death compared with persons without diabetes [3, 4]. The synchronous occurrence of diabetes…”
BackgroundKhaw, K.-T. (2001) · BMJ · doi:10.1136/bmj.322.7277.15 · Cited by 1,017 · cited 1×
“2% could lower the mortality by 10% [16].”
BackgroundDiabetes and Decline in Heart Disease Mortality in US Adults
Gu, K. (1999) · JAMA · doi:10.1001/jama.281.14.1291 · Cited by 856 · cited 1×
“However, women with diabetes appear to have experienced an increased CHD mortality [28].”
BackgroundFuller, J. H., Shipley, M. J., Rose, G., Jarrett, R. J., & Keen, H. (1983) · BMJ · doi:10.1136/bmj.287.6396.867 · Cited by 633 · cited 1×
“tion between fasting blood glucose (FBG) and cardiovascular events [6, 7].”
BackgroundSex Disparities in Treatment of Cardiac Risk Factors in Patients With Type 2 Diabetes
Wexler, D. J., Grant, R. W., Meigs, J. B., Nathan, D. M., & Cagliero, E. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.514 · Cited by 339 · cited 1×
“Earlier, it was noticed that type 2 diabetic patients without CHD had the same HbA1c levels irrespective of gender whereas female patients with CHD had higher HbA1c than respective male controls [26].”
BackgroundCause-specific mortality in a population-based study of diabetes.
Moss, S. E., Klein, R., & Klein, B. E. (1991) · American Journal of Public Health · doi:10.2105/ajph.81.9.1158 · Cited by 313 · cited 1×
“Quantitatively, subjects with diabetes have more than two-fold increased risk for cardiovascular death compared with persons without diabetes [3, 4].”
BackgroundSelvin, E., Coresh, J., Golden, S. H., Brancati, F. L., Folsom, A. R., & Steffes, M. W. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.16.1910 · Cited by 289 · cited 1×
“Recently, elevated HbA1c has been regarded as an independent risk factor for coronary heart disease (CHD) [10] and stroke [11] in subjects with or without diabetes.”
BackgroundHoward, B. V., Cowan, L. D., Go, O., Welty, T. K., Robbins, D. C., Lee, E. T., & Strong Heart Study Investigators (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1258 · Cited by 275
Type II Diabetes Abrogates Sex Differences in Endothelial Function in Premenopausal Women
Steinberg, H. O., Paradisi, G., Cronin, J., Crowde, K., Hempfling, A., Hook, G., & Baron, A. D. (2000) · Circulation · doi:10.1161/01.cir.101.17.2040 · Cited by 272
Walden, C. E., Knopp, R. H., Wahl, P. W., Beach, K. W., & Strandness, E. (1984) · New England Journal of Medicine · doi:10.1056/nejm198410113111505 · Cited by 253
Postchallenge Hyperglycemia and Mortality in a National Sample of U.S. Adults
Saydah, S. H., Miret, M., Sung, J., Varas, C., Gause, D., & Brancati, F. L. (2001) · Diabetes Care · doi:10.2337/diacare.24.8.1397 · Cited by 221 · cited 1×
“The major cause of the reduction in life expectancy in diabetic patients is associated with cardiovascular complications [1, 2]. Quantitatively, subjects with diabetes have more than two-fold increased risk for cardiovascular death compared with persons without diabetes [ 3 , 4]. The synchronous occurrence of diabetes…”
BackgroundHbA1c and Peripheral Arterial Disease in Diabetes
Selvin, E., Wattanakit, K., Steffes, M. W., Coresh, J., & Sharrett, A. R. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-2018 · Cited by 184 · cited 1×
“The impact of poor glycaemic control is so grave that increased maternal HbA1c could impair foetal long axis cardiac function [13], whereas improving glycaemic control can substantially reduce the risk of cardiovascular events in diabetics [14, 15].”
BackgroundEshaghian, S., Horwich, T. B., & Fonarow, G. C. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.10.008 · Cited by 145 · cited 1×
“It has been reported that HDL cholesterol is inversely and non-HDL cholesterol directly associated with CHD risk in diabetes patients [ 42 ].”
BackgroundEsteghamati, A., Abbasi, M., Nakhjavani, M., Yousefizadeh, A., Basa, A. L. P., & Afshar, H. (2006) · Cardiovascular Diabetology · doi:10.1186/1475-2840-5-15 · Cited by 118
Correlation among fasting plasma glucose, two-hour plasma glucose levels in OGTT and HbA1c
Ito, C., Maeda, R., Ishida, S., Sasaki, H., & Harada, H. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00187-x · Cited by 103
The impact of ethnicity and sex on subclinical cardiovascular disease: the Diabetes Heart Study
Freedman, B. I., Hsu, F., Langefeld, C. D., Rich, S. S., Herrington, D. M., Carr, J. J., Xu, J., Bowden, D. W., & Wagenknecht, L. E. (2005) · Diabetologia · doi:10.1007/s00125-005-0017-2 · Cited by 86 · cited 1×
“However, susceptibility to CVD among type 2 diabetic patients differs markedly according to ethnicity and gender [35], though converse findings also exist [36].”
BackgroundRosediani, M., Azidah, A. K., & Mafauzy, M. (2006) · PubMed · Cited by 85
Onat, A., Sarı, İ., Yazıcı, M., Can, G., Hergenç, G., & Avcı, G. Ş. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.06.056 · Cited by 80
Gardiner, H. M., Pasquini, L., Wolfenden, J., Kulinskaya, E., Li, W., & Henein, M. Y. (2005) · Heart · doi:10.1136/hrt.2005.076885 · Cited by 64 · cited 1×
“The impact of poor glycaemic control is so grave that increased maternal HbA1c could impair foetal long axis cardiac function [13], whereas improving glycaemic control can substantially reduce the risk of cardiovascular events in diabetics [14, 15].”
BackgroundChan, W. B., Tong, P. C. Y., Chow, C. C., So, W., Ng, M. C. Y., Ma, R. C. W., Osaki, R., Cockram, C. S., & Chan, J. C. N. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.497 · Cited by 59
Windler, E. E. T. (2005) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2005.06.003 · Cited by 58 · cited 2×
“Patients with type 2 diabetes often exhibit an atherogenic lipid profile (high TG and low HDL cholesterol) which greatly increases their risk of CVD compared with people without diabetes [18].”
BackgroundGlycemic Control and Prevention of Microvascular and Macrovascular Disease in The Steno 2 Study
Vaag, A. A. (2006) · Endocrine Practice · doi:10.4158/ep.12.s1.89 · Cited by 57 · cited 1×
“Vaag [17] has suggested that improving glycaemic control in patients with type 2 diabetes may be more important than treating dyslipidaemia for the prevention of both microvascular and macrovascular complications.”
BackgroundImpaired Glucose Tolerance, Diabetes, and Cardiovascular Disease
Schnell, O., & Standi, E. (2006) · Endocrine Practice · doi:10.4158/ep.12.s1.16 · Cited by 57 · cited 1×
“The major cause of the reduction in life expectancy in diabetic patients is associated with cardiovascular complications [1, 2].”
BackgroundLipid Profile Correlates With Glycemic Control in Young Patients With Type 1 Diabetes Mellitus
Ladeia, A. M. T., Adan, L., Couto-Silva, A. C., Hiltner, A. N., & Guimarães, A. C. (2006) · Preventive Cardiology · doi:10.1111/j.1520-037x.2006.4019.x · Cited by 56
Schulze, M. B., Shai, I., Manson, J. E., Li, T., Rifai, N., Jiang, R., & Hu, F. B. (2004) · Diabetologia · doi:10.1007/s00125-004-1593-2 · Cited by 48 · cited 1×
“Another study on female type 2 diabetic patients has revealed that association between non-HDL cholesterol and CHD risk is apparent in patients with elevated TG [ 43 ].”
BackgroundHigh Incidence of Glucose Intolerance in Asian-Indian Subjects With Acute Coronary Syndrome
Ramachandran, A., Snehalatha, C., Sathyamurthy, I., Shanmugam, R. M., Vishnu, N., Viswanathan, V., & Jaakko, T. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2492 · Cited by 44 · cited 1×
“4%) had normal glucose tolerance and the remaining were either diabetic or had impaired glucose tolerance [5].”
BackgroundCommunity-Based screening for cardiovascular disease and diabetes using HbA1c
Grant, T., Soriano, Y., Marantz, P. R., Nelson, I., Williams, E., Ramirez, D. C., Burg, J., & Nordin, C. (2004) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2003.12.015 · Cited by 41
Strict Glycemic Control Ameliorates the Increase of Carotid IMT in Patients with Type 2 Diabetes
Kawasumi, M., Tanaka, Y., Uchino, H., Shimizu, T., Tamura, Y., Sato, F., Mita, T., Watada, H., Sakai, K., Hirose, T., et al. (2006) · Endocrine Journal · doi:10.1507/endocrj.53.45 · Cited by 37 · cited 1×
“The impact of poor glycaemic control is so grave that increased maternal HbA1c could impair foetal long axis cardiac function [13], whereas improving glycaemic control can substantially reduce the risk of cardiovascular events in diabetics [14, 15].”
BackgroundPostprandial Hyperglycemia and Cardiovascular Disease
Gerich, J. E. (2006) · Endocrine Practice · doi:10.4158/ep.12.s1.47 · Cited by 32
Ko, G. T. C., Chan, J. C. N., Woo, J., Lau, E., Yeung, V. T. F., Chow, C. C., Li, J. K. Y., So, W. Y., Chan, W., & Cockram, C. S. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199807)15:7<573::aid-dia614>3.0.co;2-m · Cited by 30
Improved glycaemic control—an unintended benefit of a nurse‐led cardiovascular risk reduction clinic
Woodward, A., Wallymahmed, M., Wilding, J. P. H., & Gill, G. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01549.x · Cited by 27 · cited 1×
“Interestingly, attempts to reduce cardiovascular risks resulted in the improvement of HbA1c even in the absence of any specific intervention targeted at improving glycaemic control [21].”
BackgroundGiansanti, R., Rabini, R. A., Romagnoli, F., Fumelli, D., Sorichetti, P., Boemi, M., & Fumelli, P. (1999) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(99)00031-x · Cited by 23 · cited 1×
“[20] also observed significantly higher levels of hypercholesterolaemia and hyperlipidaemia in type 2 diabetic patients with CVD as compared to diabetic patients without CVD.”
BackgroundDoruk, H., Mas, M. R., Ateşkan, Ü., Işık, A. T., Sağlam, M., & Kutlu, M. (2005) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2004.11.004 · Cited by 19 · cited 1×
“1) is in agreement with earlier reports [22–24] as to the absence of a significant correlation between HbA1c and age [25].”
ResultApolipoprotein E genotype and plasma lipid levels in Caucasian diabetic patients
Morbois-Trabut, L., Chabrolle, C., Garrigue, M., Lasfargues, G., & Lecomte, P. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70279-3 · Cited by 17 · cited 3×
“Both HbA1c and FBG exhibited direct correlations with cholesterol, TG and LDL and inverse correlation with HDL; the magnitude of significance for all these lipid parameters being greater with HbA1c than FBG.”
BackgroundInfluentialCardiovascular risk factors in Saudi Arabian and non-Saudi Arabian diabetic patients in Saudi Arabia
Akbar, D. H., Ahmed, M. M., & Algamdi, A. A. (2003) · Eastern Mediterranean Health Journal · doi:10.26719/2003.9.5-6.884 · Cited by 13
Ciardullo, A. V., Azzolini, L., Bevini, M., Cadioli, T., Malavasi, P., Morellini, A., Daghio, M. M., Guidetti, P., Lorenzetti, M., Carapezzi, C., et al. (2004) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2004.672 · Cited by 5
Cited by
Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients
Sherwani, S. I., Khan, H. A., Ekhzaimy, A., Masood, A., & Sakharkar, M. K. (2016) · Biomarker Insights · doi:10.4137/bmi.s38440 · Cited by 1,381
Self-citationEllagic acid: Pharmacological activities and molecular mechanisms involved in liver protection
García-Niño, W. R., & Zazueta, C. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.04.008 · Cited by 274
Geta, E. T., Terefa, D. R., Hailu, W. B., Olani, W., Merdassa, E., Dessalegn, M., Gelchu, M., & Diriba, D. C. (2024) · PLOS ONE · doi:10.1371/journal.pone.0306296 · Cited by 21
Therapeutic Role of Mango Peels in Management of Dyslipidemia and Oxidative Stress in Obese Females
Arshad, F., Umbreen, H., Aslam, I., Hameed, A., Aftab, K., Al-Qahtani, W. H., Aslam, N., & Noreen, R. (2021) · BioMed Research International · doi:10.1155/2021/3094571 · Cited by 20
Metadata
- Authors
- Khan, H. A., Sobki, S. H., & Khan, S. A.
- Venue
- Clinical and Experimental Medicine
- Published
- 2007-03
- Volume
- 7
- Issue
- 1
- Pages
- 24-29
- ISSN
- 1591-8890 (ISSN-L)
- 1591-9528
- OpenAlex
- W1965344989
- Cited by
- 220
- References
- 39
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.